Genesco Q2 EPS Beats, Raises FY27 Guidance to High End of Range
GCO sits 57% above its 52-week low of $21.925.
Summary
Genesco reported Q2 FY27 GAAP EPS of $0.32, beating expectations, and raised full-year adjusted EPS guidance to the high end of $2.00-$2.40. The company also repurchased 317,503 shares in Q3 through August 31.
Key Events · Earnings and Guidance · GCO
-
Q2 EPS Beats Expectations
GAAP EPS of $0.32 vs ($1.79) last year; Non-GAAP EPS of ($0.83) vs ($1.14) last year. Net sales of $530M, down 3% YoY.
-
Tariff Refund Boosts Results
Received $22.5M in tariff refunds during Q2, contributing to a 560 bps improvement in GAAP gross margin to 51.4%.
-
FY27 Guidance Raised
Adjusted EPS guidance raised to high end of $2.00-$2.40 range, up from midpoint previously. Operating income expected at high end of $34-$40M range.
-
Share Repurchases Resume
Repurchased 317,503 shares in Q3 through August 31, 2026; $18.8M remaining under expanded authorization.
Analysis · GCO · Trade & Services
A $22.5M tariff refund and improved gross margins drove a strong Q2, with GAAP EPS of $0.32 versus a loss of $1.79 last year. Management raised full-year adjusted EPS guidance to the high end of the $2.00-$2.40 range, up from the midpoint previously. The company also repurchased 317,503 shares in Q3 through August 31, signaling confidence in the stock. This comes amid an ongoing proxy contest with activist investors, making the earnings beat and guidance raise a key data point for shareholders evaluating the board's performance.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCO was trading at $34.44 on NYSE in the Trade & Services sector, with a market capitalization of approximately $372.3M. The 52-week trading range was $21.93 to $43.60. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.